Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $43.20 Average Target Price from Brokerages

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has been given an average rating of “Buy” by the ten analysts that are currently covering the firm, MarketBeat reports. Nine investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target […]

Related Keywords

Piper Sandler ,Jeff Cislini ,Sushil Patel ,Raymond James ,Nasdaq ,Revolution Medicines Inc ,Janus Henderson Group ,Securities Exchange Commission ,Revolution Medicines Company Profile ,Needham Company ,Paloma Partners Management Co ,Farallon Capital Management ,Revolution Medicines ,Get Free Report ,Medicines Trading Down ,General Counsel Jeff Cislini ,Exchange Commission ,Director Sushil Patel ,Capital Management ,Henderson Group ,Get Free ,Revolution Medicines Daily ,